Laryngeal Cancer

Perform flexible laryngoscopy to document primary subsite, mucosal extent, vocal-cord mobility, airway adequacy, and swallowing function, then obtain direct laryngoscopy with biopsy for definitive diagnosis. Direct laryngoscopy and biopsy remain the diagnostic gold standard; imaging complements pathology by assessing local extension, resectability, prognosis, and treatment planning. PubMedPubMedSystemic therapy in the curative treatment of laryngeal cancer - PMC

Stage glottic and supraglottic primaries with attention to local extension and vocal-cord fixation. Nodal staging incorporates nodal size, number, laterality, and extranodal extension; these features move management from primary-only treatment toward planned neck treatment and multimodality therapy. PubMedPubMedLaryngeal Cancer - StatPearls - NCBI Bookshelf

Obtain contrast-enhanced CT of the neck when defining deep extension or advanced disease. CT identifies invasion of the pre-epiglottic space, paraglottic space, and subglottic extension; cartilage invasion is particularly consequential because it supports T4 classification. If early mucosal disease or soft-tissue invasion remains unclear on CT, use MRI and/or PET/CT for further delineation. PubMedPubMedHead and Neck Squamous Cell Cancer: Approach to Staging and Surveillance - Diseases of the Brain, Head and Neck, Spine 2024-2027 - NCBI Bookshelf

Use FDG-PET/CT in initial staging when stage III or IV laryngeal cancer is suspected. PET/CT has greater diagnostic accuracy than conventional imaging for staging head and neck squamous cell carcinoma and can reduce unnecessary additional procedures or treatment. PubMedPubMedGuidelines for the Surgical Management of Laryngeal Cancer: Korean Society of Thyroid-Head and Neck Surgery

Treat most stage I–II laryngeal cancers with one definitive modality: surgery or radiotherapy. In T1–T2 glottic squamous cell carcinoma, systematic reviews show comparably high cure rates with transoral laser/endolaryngeal surgery and radiotherapy; reported survival is high with either radiotherapy or transoral microsurgery. PubMed+2PubMedOverview of glottic laryngeal cancer treatment recommendation changes in the NCCN guidelines from 2011 to 2022PubMedSystemic therapy in the curative treatment of laryngeal cancer - PMCPubMedLaryngeal Cancer - StatPearls - NCBI Bookshelf

Choose transoral/endolaryngeal resection when complete endoscopic excision is feasible and expected voice and swallowing outcomes are acceptable. Choose definitive radiotherapy when anatomy, exposure, anticipated resection-related functional loss, patient preference, or institutional expertise favors a nonsurgical approach. Functional preservation should be a central discriminator because oncologic outcomes are similar in appropriately selected early disease. PubMed+1PubMedGuidelines for the Treatment of Laryngeal Cancer from the Korean Society of Head and Neck SurgeryPubMedSystemic therapy in the curative treatment of laryngeal cancer - PMC

For clinically node-negative early glottic tumors, direct treatment to the primary rather than routinely treating the neck. Early glottic cancers have limited submucosal lymphatic networks and uncommon nodal disease, making single-modality primary treatment generally sufficient. PubMed+1PubMedGuidelines for the Treatment of Laryngeal Cancer from the Korean Society of Head and Neck SurgeryPubMedSystemic therapy in the curative treatment of laryngeal cancer - PMC

Do not apply the same neck strategy to supraglottic disease by default. Subsite-specific patterns of spread differ, and nodal status must be incorporated into the treatment plan rather than inferred from glottic cancer paradigms. PubMedPubMedLaryngeal Cancer - StatPearls - NCBI Bookshelf

For locally advanced laryngeal cancer, select among primary chemoradiotherapy, surgery followed by radiotherapy, and combined-modality treatment. Advanced-stage disease has poorer prognosis than stage I–II disease and generally warrants multimodality therapy rather than primary-only treatment. PubMedPubMedLaryngeal Cancer - StatPearls - NCBI Bookshelf

Use a larynx-preservation approach only after confirming accurate staging and evaluating tumor subsite, vocal-cord mobility, anterior commissure involvement, nodal status, age, comorbidity, baseline function, treatment compliance, psychosocial and logistical factors, and local expertise. The goal is function preservation without compromising oncologic control, not avoidance of surgery at any cost. PubMedPubMedSystemic therapy in the curative treatment of laryngeal cancer - PMC

Discuss total laryngectomy when tumor extent or baseline dysfunction makes reliable functional preservation unlikely, and for surgical salvage of persistent or recurrent disease when an organ-preserving approach has failed. Procedure selection must also account for resectability: unresectable disease, carotid encasement, and distant metastases are contraindications to curative total laryngectomy. PubMedPubMedTotal Laryngectomy - StatPearls - NCBI Bookshelf

In selected advanced supraglottic tumors, partial-laryngeal procedures may remain feasible. T3 disease with pre-epiglottic space invasion but without transglottic spread can be considered for supraglottic partial laryngectomy; arytenoidectomy requires extended supraglottic laryngectomy and is associated with longer recovery and more serious complications. PubMedPubMedGuidelines for the Surgical Management of Laryngeal Cancer: Korean Society of Thyroid-Head and Neck Surgery

After treatment for early glottic cancer, perform structured observation with endoscopic examination and risk-adapted use of radiologic imaging. Timely recognition of limited residual or recurrent disease can permit salvage surgery or salvage radiotherapy/chemoradiotherapy while preserving organ function. PubMedPubMedEuropean Laryngological Society consensus statement on optimal monitoring schedules after treatment for early glottic cancer: a risk-stratification - PMC

Risk stratify follow-up rather than relying only on stage. A consensus framework for T1–T2N0 early glottic cancer distinguishes surgical from nonsurgical pathways and incorporates endoscopic examination, imaging, and thyroid-function screening; this addresses the practical need to detect recurrence and functional complications after either modality. PubMedPubMedEuropean Laryngological Society consensus statement on optimal monitoring schedules after treatment for early glottic cancer: a risk-stratification - PMC

When recurrence is suspected clinically or endoscopically, re-establish local extent and resectability before salvage selection. Imaging is central for defining deep tissue involvement, cartilage invasion, and disease beyond clinical examination; persistent or recurrent disease after larynx-preserving therapy may require salvage total laryngectomy. PubMed+1PubMedHead and Neck Squamous Cell Cancer: Approach to Staging and Surveillance - Diseases of the Brain, Head and Neck, Spine 2024-2027 - NCBI BookshelfPubMedTotal Laryngectomy - StatPearls - NCBI Bookshelf

After total laryngectomy, place the patient in a unit experienced with laryngectomy care, provide frequent stoma suctioning during the first postoperative days, and monitor for bleeding, edema, and airway compromise. These are recognized early complications requiring direct observation and prompt airway intervention through the stoma. PubMedPubMedTotal Laryngectomy - StatPearls - NCBI Bookshelf

Place clear bedside and room signage identifying a permanent neck breather. The patient cannot be intubated orally or nasally after total laryngectomy; emergency oxygenation and airway access must be directed through the tracheal stoma. PubMedPubMedTotal Laryngectomy - StatPearls - NCBI Bookshelf

In preoperative counseling, frame total laryngectomy as an oncologic and functional decision: it may be necessary for disease not amenable to a reliable preservation strategy, while speech and swallowing rehabilitation require coordinated multidisciplinary planning. PubMedPubMedTotal Laryngectomy - StatPearls - NCBI Bookshelf